These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1424860)

  • 1. Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B
    Chest; 1992 Nov; 102(5):1407-12. PubMed ID: 1424860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
    Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of captopril on hemodynamics and blood gases in chronic obstructive lung disease with pulmonary hypertension.
    Bertoli L; Lo Cicero S; Busnardo I; Rizzato G; Montanari G
    Respiration; 1986; 49(4):251-6. PubMed ID: 3520734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Precapillary pulmonary hypertension: effect of Captopril].
    Sanguinetti M; Galiè N; Magelli C; Orselli L; Magnani B
    G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
    Cozzi F; Montisci R; Marotta H; Bobbo F; Durigon N; Ruscazio M; Sfriso P; Iliceto S; Todesco S
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():49-53. PubMed ID: 16919011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease.
    Niarchos AP; Whitman HH; Goldstein JE; Laragh JH
    Am Heart J; 1982 Oct; 104(4 Pt 1):834-8. PubMed ID: 6751058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril.
    Sfikakis PP; Kyriakidis MK; Vergos CG; Vyssoulis GP; Psarros TK; Kyriakidis CA; Mavrikakis ME; Sfikakis PP; Toutouzas PK
    Am J Med; 1991 May; 90(5):541-6. PubMed ID: 2029011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril in primary pulmonary hypertension.
    Leier CV; Bambach D; Nelson S; Hermiller JB; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Jan; 67(1):155-61. PubMed ID: 6336605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary hypertension in diffuse scleroderma and the CREST syndrome].
    Presetnik M; Music E; Kolsek B; Rozman B
    Plucne Bolesti; 1989; 41(1-2):5-7. PubMed ID: 2798573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.
    Rich S; Martinez J; Lam W; Rosen KM
    Br Heart J; 1982 Sep; 48(3):272-7. PubMed ID: 7049203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute and long-term effects of captopril in resistance-induced pulmonary hypertension in childhood and adolescence].
    Müller-Deile K; Rupprath G; Vogt J
    Monatsschr Kinderheilkd; 1986 Dec; 134(12):854-7. PubMed ID: 3102952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
    Lie JT
    Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome.
    Glikson M; Pollack A; Dresner-Feigin R; Galun E; Rubinow A
    Chest; 1990 Sep; 98(3):759-61. PubMed ID: 2394157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated.
    Bertoli L; Fusco M; Lo Cicero S; Micallef E; Busnardo I
    Postgrad Med J; 1986; 62 Suppl 1():47-51. PubMed ID: 3022273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of captopril in hypoxic pulmonary hypertension. Comparison with transient oxygen administration.
    Boschetti E; Tantucci C; Cocchieri M; Fornari G; Grassi V; Sorbini CA
    Respiration; 1985; 48(4):296-302. PubMed ID: 3909277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
    Oudiz RJ; Schilz RJ; Barst RJ; Galié N; Rich S; Rubin LJ; Simonneau G;
    Chest; 2004 Aug; 126(2):420-7. PubMed ID: 15302727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension.
    Patakas D; Georgopoulos D; Rodini H; Christaki P
    Postgrad Med J; 1988 Mar; 64(749):193-5. PubMed ID: 3050941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary arterial hypertension in connective tissue disease].
    Cottin V
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CREST syndrome--successful reduction of pulmonary hypertension by captopril.
    Prouse PJ; Lahiri A; Gumpel JM
    Postgrad Med J; 1984 Oct; 60(708):672-4. PubMed ID: 6387690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.